Who can use OMICtools?
Anyone. It's free and open to the public.
Anyone. It's free and open to the public.
Yes - both developers and users can submit new tools and share them with the biomedical community. Submitted tools are then manually checked by OMICtools curators before inclusion into the directory.
You can submit three types of resources: programs, databases and links to literature.
You can submit a) articles that evaluate programs and databases, b) surveys of omic tools and c) protocols.
If you think an important category is missing, you can suggest an addition. You can either suggest a new category during the submission (an option is available) or contact us.
Yes - We make no difference between a free and commercial tool.
Yes - OMICtools catalogs unpublished tools.
Submitted tools cannot be edited. However, you can simply resubmit it. Curators will only take the last submission in consideration.
Anyone - First select the tool and then click on the links below its image. Your comments are quickly checked before diffusion to prevent spamming.
Any question/problem related to the omic tools. We welcome comments that are written clearly and simply.
The Resource Identification Initiative (#RII) is designed to help researchers sufficiently cite the key resourcesused to produce the scientific findings reported in the biomedical literature. In collaboration with the Neuroscience Information Framework (NIF), OMICtools has added a unique Research Resource Identifiers (RRIDs) for each analytical tool.
If you would like to help as a curator, please contact us.
Numerous programs are developed for a specific analytical step (quality control, normalization, quantification, etc.). A software pipeline automates the analysis by chaining/combining a number of specific analysis tools together.
The exact number of tools added in OMICtools is indicated in the widget statistics. The difference arises from the fact that a tool can be in different categories (up to three).
By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.